Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Zou

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Urolithiasis|April 13, 2024
Develop a radiomics-based machine learning model to predict the stone-free rate post-percutaneous nephrolithotomyXin Chang Zou, Cheng Wei Luo, Rong Man Yuan, et al.
Frontiers in Oncology|October 13, 2025
Ensemble machine learning models for predicting bone metastasis in bladder cancerZhan Jiang Yu, Xiang Da Xu, Xin Chang Zou, et al.
Journal of Orthopaedic Surgery and Research|March 27, 2024
Newly designed plate for the treatment of posterolateral tibial plateau fractures: a finite element analysisZhaokui Yan, Chang Zou, Guy Romeo Kenmegne, et al.
Medicine|September 23, 2024
Evaluation of the efficacy of perioperative tranexamic acid in patients with pelvic and acetabular fractures: A systematic review and meta-analysisYijie Yin, Jiabao Jiang, Chang Zou, et al.
Translational Oncology|March 27, 2022
LncRNA GIHCG promoted the proliferation and migration of renal cell carcinoma through regulating miR-499a-5p/XIAP axisShu-Ying Zhu, Hong-Chang Zou, Ming-Ming Gao, et al.
Applied Biochemistry and Biotechnology|June 13, 2008
Effect of cysteine modification on creatine kinase aggregationHe-Chang Zou, Zhi-Rong Lü, Ye-Jing Wang, et al.
World Journal of Surgical Oncology|May 27, 2026
Exploring the advantages of mixed reality technology in Robot-assisted laparoscopic partial adrenalectomyXin Chang Zou, Zhe Hao Wu, Xiang Da Xu, et al.
Frontiers in Immunology|May 15, 2026
Disitamab vedotin (RC48) combined with PD-1 inhibitors in locally advanced or metastatic urothelial carcinoma: clinical outcomes and prognostic factors from a multicenter real-world studyXin Chang Zou, Lie Yu Xu, Yu Yang Yuan, et al.
Cancer Medicine|April 30, 2022
Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALLXuemei Chen, Feiqiu Wen, Zhu Li, et al.
The Journal of Pathology|July 29, 2014
Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilizationShan Yu, Zhenyu Xu, Chang Zou, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Urolithiasis|April 13, 2024
Develop a radiomics-based machine learning model to predict the stone-free rate post-percutaneous nephrolithotomyXin Chang Zou, Cheng Wei Luo, Rong Man Yuan, et al.
Frontiers in Oncology|October 13, 2025
Ensemble machine learning models for predicting bone metastasis in bladder cancerZhan Jiang Yu, Xiang Da Xu, Xin Chang Zou, et al.
Journal of Orthopaedic Surgery and Research|March 27, 2024
Newly designed plate for the treatment of posterolateral tibial plateau fractures: a finite element analysisZhaokui Yan, Chang Zou, Guy Romeo Kenmegne, et al.
Medicine|September 23, 2024
Evaluation of the efficacy of perioperative tranexamic acid in patients with pelvic and acetabular fractures: A systematic review and meta-analysisYijie Yin, Jiabao Jiang, Chang Zou, et al.
Translational Oncology|March 27, 2022
LncRNA GIHCG promoted the proliferation and migration of renal cell carcinoma through regulating miR-499a-5p/XIAP axisShu-Ying Zhu, Hong-Chang Zou, Ming-Ming Gao, et al.
Applied Biochemistry and Biotechnology|June 13, 2008
Effect of cysteine modification on creatine kinase aggregationHe-Chang Zou, Zhi-Rong Lü, Ye-Jing Wang, et al.
World Journal of Surgical Oncology|May 27, 2026
Exploring the advantages of mixed reality technology in Robot-assisted laparoscopic partial adrenalectomyXin Chang Zou, Zhe Hao Wu, Xiang Da Xu, et al.
Frontiers in Immunology|May 15, 2026
Disitamab vedotin (RC48) combined with PD-1 inhibitors in locally advanced or metastatic urothelial carcinoma: clinical outcomes and prognostic factors from a multicenter real-world studyXin Chang Zou, Lie Yu Xu, Yu Yang Yuan, et al.
Cancer Medicine|April 30, 2022
Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALLXuemei Chen, Feiqiu Wen, Zhu Li, et al.
The Journal of Pathology|July 29, 2014
Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilizationShan Yu, Zhenyu Xu, Chang Zou, et al.
Pageof 20